The FDA's Digital Health Center of Excellence is here. But the real story behind this 'innovation' isn't patient care—it's regulatory capture. Explore the hidden costs.
Vizient's call for 2026 tech applications reveals the hidden battle for control over future healthcare technology investment.
Dr. Dennis Slamon's honor in precision medicine masks the crushing reality of high drug costs and access inequality in modern healthcare.
NYC Health + Hospitals celebrates a milestone in **robotic-assisted bronchoscopy**. But behind the PR spin lies a critical debate on medical technology adoption and cost.
The hidden truth about medical research isn't the drug, it's the math. Unmasking the biostatisticians driving clinical trial outcomes.
The WEF's focus on women's health investment isn't just altruism—it's a massive economic pivot. Unpacking the hidden winners and losers in this new frontier of healthcare funding.
Forget the platitudes. We dissect the three 'sustainable digital health' principles and expose who truly profits from this data gold rush.
The FDA's new digital health services pilot, lauded by the AHA, signals a massive shift in medical liability. Discover who really benefits from this regulatory experiment.